Indivior Applies for Approval in Treating Opioid Abuse in U.S.

British pharmaceutical leader Indivior Plc announced this week its new drug application (NDA) to the U.S. Food and Drug Administration for its drug treating opioid use disorder (OUD). The drug, RBD-6000 acts as a monthly injectable opioid which in conjunction with...